<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01331629</url>
  </required_header>
  <id_info>
    <org_study_id>ART-THERAPIE</org_study_id>
    <nct_id>NCT01331629</nct_id>
  </id_info>
  <brief_title>Impact of Art Therapy on Fatigue and Quality of Life of Patients Treated With Adjuvant Radiotherapy for Breast Cancer</brief_title>
  <acronym>ART-THERAPIE</acronym>
  <official_title>Impact of Art Therapy on Fatigue and Quality of Life of Patients Treated With Adjuvant Radiotherapy for Breast Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Francois Baclesse</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ligue contre le cancer, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre Francois Baclesse</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare intervention by Art-therapy to standard care in
      patients treated with adjuvant radiotherapy for breast cancer and evaluate the fatigue.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 2010</start_date>
  <completion_date type="Actual">September 2016</completion_date>
  <primary_completion_date type="Actual">May 2015</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>evaluate persistent fatigue</measure>
    <time_frame>up to 12 months after radiotherapy</time_frame>
    <description>Estimate the decrease in the proportion of patients with persistent fatigue after one month of radiotherapy in patients receiving an approach from art therapy as a complement to standard care compared to those with care standard alone.
Evaluated by auto-questionnary</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evaluate the quality of life patients.</measure>
    <time_frame>up to 12 months after radiotherapy</time_frame>
    <description>Evaluate the quality of life patients (by auto-questionnary)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assess the impact of the condition of patients on the reactions, depression and anxiety of relatives Assess the impact of the condition of patients on the reactions, depression and anxiety of relatives</measure>
    <time_frame>up to 12 months after radiotherapy</time_frame>
    <description>Assess the impact of the condition of patients on the reactions, depression and anxiety of relatives (by auto-questionnary)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluate the fatigue away from the treatment (at 6 months and 1 year) of patients</measure>
    <time_frame>6 months and 12 months after treatment</time_frame>
    <description>Evaluate the fatigue away from the treatment (at 6 months and 1 year) of patients (by auto-questionnary)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluate the anxiety of patients</measure>
    <time_frame>up 12 months after radiotherapy</time_frame>
    <description>Evaluate the anxiety of patients (by auto-questionnary)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>evaluate the depression of patients</measure>
    <time_frame>up 12 months after study</time_frame>
    <description>evaluate the depression of patients (by auto-questionnary)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluate the quality of life away from the treatment (at 6 months and 1 year) of patients</measure>
    <time_frame>6 months and 1 year after treatment</time_frame>
    <description>Evaluate the quality of life away from the treatment (at 6 months and 1 year) of patients (by auto-questionnary)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">322</enrollment>
  <condition>Breast Cancer</condition>
  <arm_group>
    <arm_group_label>ART-THERAPIE</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>supported in art therapy with other supportive care available in the facility</description>
  </arm_group>
  <arm_group>
    <arm_group_label>standard group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>standard care (supportive care available in each facility)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>ART-THERAPIE</intervention_name>
    <description>8 sessions of art therapy during radiotherapy</description>
    <arm_group_label>ART-THERAPIE</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Breast cancer surgery (invasive or in situ) by conservative surgery

          -  Age ≥ 18 years

          -  Indication of adjuvant radiotherapy

          -  Adjuvant chemotherapy allowed

          -  Agreeing to participate in a clinical study

          -  Able to participate in a clinical trial

        Exclusion Criteria:

          -  Metastatic Breast Cancer

          -  Personal history of breast cancer
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Centre François BACLESSE</name>
      <address>
        <city>Caen</city>
        <state>Calvados</state>
        <zip>14076</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU</name>
      <address>
        <city>Grenoble</city>
        <state>Isère</state>
        <zip>38000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Oscar LAMBRET</name>
      <address>
        <city>Lille</city>
        <state>Nord</state>
        <zip>59000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Henri Becquerel</name>
      <address>
        <city>Rouen</city>
        <state>Seine Maritime</state>
        <zip>76 000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Antoine LACASSAGNE</name>
      <address>
        <city>Nice</city>
        <zip>06</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institut Jean Godinot</name>
      <address>
        <city>Reims</city>
        <zip>51726</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 5, 2011</study_first_submitted>
  <study_first_submitted_qc>April 7, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 8, 2011</study_first_posted>
  <last_update_submitted>March 13, 2017</last_update_submitted>
  <last_update_submitted_qc>March 13, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 14, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>breast cancer</keyword>
  <keyword>fatigue</keyword>
  <keyword>quality of life</keyword>
  <keyword>art-therapie</keyword>
  <keyword>adjuvant radiotherapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
    <mesh_term>Fatigue</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

